» Articles » PMID: 8509785

Mortality from Parkinson's Disease in England and Wales 1921-89

Overview
Date 1993 Jun 1
PMID 8509785
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mortality from Parkinson's disease in England and Wales was re-examined using published government statistics. The 300% increase in the crude mortality rate between 1921 and 1989 was largely attributable to the increase in the elderly population who suffer a higher prevalence of the disease. The dramatic fall in 1940 and rise in 1984 were artefacts caused by changes in certification. Age-specific mortality fell after 1940 in all groups below 70 years and in both sexes, but increased in those over 75 years. Analysis by birth cohort showed a progressive decline in mortality at younger ages with successive cohorts but stable mortality in the elderly. Younger patients were probably misclassified cases of "late-onset" Parkinsonism following encephalitis lethargica who can be differentiated from older cases of idiopathic Parkinson's disease. Mortality decreased in all age groups in the 1970s but then increased in the early 1980s. This is comparable to trends in the United States and Scandinavia and suggests that the beneficial effects of levodopa delay death for several years.

Citing Articles

The long-term trend of Parkinson's disease incidence and mortality in China and a Bayesian projection from 2020 to 2030.

Chen F, Chen S, Si A, Luo Y, Hu W, Zhang Y Front Aging Neurosci. 2022; 14:973310.

PMID: 36185486 PMC: 9520003. DOI: 10.3389/fnagi.2022.973310.


Mortality of People with Parkinson's Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration.

Okunoye O, Horsfall L, Marston L, Walters K, Schrag A Mov Disord. 2021; 36(12):2811-2820.

PMID: 34351000 PMC: 7612920. DOI: 10.1002/mds.28727.


Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease.

Hare D, Cardoso B, Raven E, Double K, Finkelstein D, Szymlek-Gay E NPJ Parkinsons Dis. 2017; 3:1.

PMID: 28649601 PMC: 5460187. DOI: 10.1038/s41531-016-0004-y.


The rise of mortality from mental and neurological diseases in Europe, 1979-2009: observational study.

Mackenbach J, Karanikolos M, Looman C BMC Public Health. 2014; 14:840.

PMID: 25118099 PMC: 4139616. DOI: 10.1186/1471-2458-14-840.


The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease.

Estupinan D, Nathoo S, Okun M Parkinsons Dis. 2013; 2013:167843.

PMID: 23853734 PMC: 3693163. DOI: 10.1155/2013/167843.


References
1.
HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View

2.
Kessler I . Parkinson's disease in epidemiologic perspective. Adv Neurol. 1978; 19:355-84. View

3.
Curtis L, Lees A, STERN G, Marmot M . Effect of L-dopa on course of Parkinson's disease. Lancet. 1984; 2(8396):211-2. DOI: 10.1016/s0140-6736(84)90493-8. View

4.
HOEHN M . Parkinson's disease: progression and mortality. Adv Neurol. 1987; 45:457-61. View

5.
Mattock C, Marmot M, Stern G . Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. J Neurol Neurosurg Psychiatry. 1988; 51(6):753-6. PMC: 1033143. DOI: 10.1136/jnnp.51.6.753. View